Actively Recruiting
Evaluating Expert Review and Dose Summation Software to Improve Re-irradiation Treatment Planning with Curative Intent
Led by Centre Leon Berard · Updated on 2026-09-15
100
Participants Needed
10
Research Sites
104 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating a standardized process that combines expert review and advanced software to improve treatment planning for patients undergoing re-irradiation with curative intent. This study aims to determine how often this approach changes treatment plans by using a group of radiotherapists and physicists to validate re-irradiation indications and dose accumulations. The study addresses challenges in managing dose limits to organs at risk during repeat radiation treatments, aiming to reduce treatment inequalities across centers. The intervention involves a multidisciplinary and multicenter validation process where technical data from previous and planned irradiations are reviewed using deformable fusion software called MiM. This software sums doses in Equivalent Dose 2 Grays EQD2 to evaluate cumulative radiation exposure. Patients undergo initial opinion assessment, followed by collective expert reviews of imaging, dose plans, and dose summations in several steps. If re-irradiation is validated, patients proceed with treatment according to the validated plan. Participants are followed for up to two years after re-irradiation to monitor treatment tolerance and effectiveness through standard practice visits approximately every three months. Outcomes measured include the rate of treatment plan changes due to the intervention, local control rates at multiple time points up to 24 months, safety, and impacts on clinical practices. Dose summation timing and treatment adherence are also evaluated. The study enrollment is for adults aged 18 years and older who meet specific clinical criteria for curative re-irradiation.
CONDITIONS
Brief Title
Contribution of Multicenter Expertise and Deformable Fusion Software for Re-irradiations With Curative Intent
Research Team
M
Marie-Pierre SUNYACH, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here